Cancer Hospital of Yunnan provinceal Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2017
NCT03097848
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Yunnan Cancer Hospital | Yunnan Provincial Cancer Hospital